Your session is about to expire
← Back to Search
Topical Bacteria + Cardamom for Eczema
Study Summary
This trial tests whether a topical formulation of live bacteria and cardamom seeds can improve symptoms of atopic dermatitis and last beyond active treatment.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Has Active met the standards for federal authorization?
"Our team has assigned a rating of 3 to the safety profile for Active due to its designation as a Phase 3 trial, which implies there is existing evidence supporting both efficacy and security."
Does the age of participants factor into consideration for this medical research?
"This clinical trial has a wide age range of participants, from 2 to 100 years old. There are 94 studies for minors and 175 trials for seniors aged 65 or older."
Is enrollment still open for this clinical experiment?
"According to information retrieved from clinicaltrials.gov, this study is no longer actively recruiting participants. Initially published on October 20th of 2023, the last update was made a day later and there are 242 other medical trials that require patient recruitment at present."
What criteria must be met to participate in this experimentation?
"This clinical trial is searching for 240 individuals with atopic dermatitis, aged between 2 and 100 years old."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger